UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046560
Receipt number R000052932
Scientific Title The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy
Date of disclosure of the study information 2022/01/06
Last modified on 2022/01/06 10:48:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy

Acronym

The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy

Scientific Title

The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy

Scientific Title:Acronym

The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will clarify whether the guidance of pelvic floor muscle exercises under abdominal ultrasonography, which could monitor the movement of pelvic floor muscles, contributes to the improvement of urinary incontinence rate in comparison with the paper-based pelvic floor muscle training guidance group.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Urinary incontinence rate during hospitalization and at 1,3,6 months after operation.

Key secondary outcomes

(1)Mental burden of performing ultrasonic examination(2)Do you feel that pelvic floor muscle exercises contribute to the improvement of urinary incontinence? (questionnaire) (3)Whether they feel they are getting effective training. (questionnaire)(4)Whether pelvic floor muscle training is still being provided after discharge from the hospital (questionnaire)(5)How do you feel about the degree of urinary incontinence (questionnaire)?(6)Urinary incontinence rate in the nerve-sparing group(7)Urinary incontinence rate in the non-nerve-preserving group.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

The subjects were patients undergoing robot assisted radical prostatectomy(RARP). Fifty patients received pelvic floor muscle exercise instruction on ultrasound in addition to paper instruction. The survey will include measurements of daily urine volume and frequency, in-diaper urinary incontinence volume, and urinary incontinence rate, as well as a questionnaire on the implementation and effectiveness of the training. Allocation method: After obtaining consent to participate in the study, a distinction was made between groups of patients who underwent nerve-sparing and non-sparing techniques. Then the instructional method was assigned in each. Among the nerve-sparing/non-nerve sparing techniques, the age group was divided by decade. The odd numbers in the built-in order are divided into the instruction group under abdominal ultrasound, and the even numbers are divided into the instruction group on paper.
Instruct pelvic floor muscle training using pamphlets with/without abdominal ultrasonography before and after surgery. From the day after removal of the urethral catheter, daily urine volume and frequency, as well as the amount of urinary incontinence in the diaper, were measured. The urinary incontinence rate is calculated from the daily urine volume and the amount of urinary incontinence in the diaper. In addition, a questionnaire survey will be conducted in the period leading up to discharge from the hospital. At the outpatient visit 1 month, 3 months, and 6 months after discharge, the research members collect information on the daily urine volume and frequency, and the amount of urinary incontinence in the diaper from the urination diary. The urinary incontinence rate is calculated.

Interventions/Control_2

Fifty patients who underwent RARP, will be trained with only paper-based pelvic floor muscle exercise instruction.
In this group, as in the therapeutic intervention group, the groups were divided by the presence or absence of nerve preservation and stratified by age.
The content of the survey is the same as in the treatment intervention group.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Patients who meet all of the following criteria are included.
(1) Robot-assisted radical prostatectomy patient.
(2) Age: At the time of obtaining consent, the age is 50 years or older.
(3) Gender: Male.
(4)Inpatient / Outpatient: Inpatient and outpatient.
(5) Patients who have fully understood the sufficient explanation of this study and have given written consent of their own free will.

Key exclusion criteria

(1) Patients with cognitive decline who are judged by the principal investigator. And sub-investigators to be unsuitable as subjects, and patients who cannot understand the instruction and cannot perform pelvic floor muscle training on their own will.
(2) In addition, patients who are judged by the principal investigator to be inappropriate as research subjects.
(3) Patients who continue to take concomitantly prohibited or excluded drugs after surgery.
Banned drugs: Drugs that may reduce urinary incontinence.
1)Stress Urinary Incontinence Treatment.
2)Overactive bladder remedies.
Concomitant exclusions: Drugs that may reduce urinary incontinence.
1)Other anticholinergic agents.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Issei
Middle name
Last name Hirai

Organization

University of Fukui Hospital

Division name

Nursing Department

Zip code

910-1193

Address

23-3 Matsuoka Shimoaizuki,Eiheiji-cho,Yoshida-gun,Fukui 910-1193 Japan

TEL

0776-61-3111

Email

isseihri@u-fukui.ac.jp


Public contact

Name of contact person

1st name Issei
Middle name
Last name Hirai

Organization

University of Fukui Hospital

Division name

Nursing Department

Zip code

910-1193

Address

23-3 Matsuoka Shimoaizuki,Eiheiji-cho,Yoshida-gun,Fukui 910-1193 Japan

TEL

0776-61-3111

Homepage URL


Email

isseihri@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Support Center/University of Fukui Hospital

Address

23-3 Matsuoka Shimoaizuki,Eiheiji-cho,Yoshida-gun,Fukui 910-1193 Japan

Tel

0776-61-8529

Email

chiken@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 09 Month 25 Day

Date of IRB

2020 Year 09 Month 25 Day

Anticipated trial start date

2020 Year 09 Month 25 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 06 Day

Last modified on

2022 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052932